Based on these results, it is reasonable to assume that BST2, TLR2, and LGALS3 are implicated in the abnormal activation of microglia or astrocytes and eventually lead to the neurotoxic effect causing impairment MNs during ALS disease progression. Here, LGALS3 is linked to amyotrophic lateral sclerosis.